Jecho Biopharmaceuticals Co., Ltd.

This study tested a new medicine called JL14002 against a standard treatment (ranibizumab) for wet age-related macular degeneration, a leading cause of vision loss. 443 adults aged 50-80 took part. The main goal was to see if the new drug could improve vision as well as the stand…

This early-stage study tested a single injection of JL15003 in 17 adults whose glioblastoma brain cancer had come back after standard treatments. The main goal was to check safety and find the best dose, while also looking at whether the treatment could shrink tumors or help peop…